Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
09 May 2019Website:
http://www.quincetx.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 17:48:47 GMTDividend
Analysts recommendations
Institutional Ownership
QNCX Latest News
Two microcap biotech stocks to consider for the science-challenged among us.
What type of business is Quince Therapeutics?
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
What sector is Quince Therapeutics in?
Quince Therapeutics is in the Healthcare sector
What industry is Quince Therapeutics in?
Quince Therapeutics is in the Biotechnology industry
What country is Quince Therapeutics from?
Quince Therapeutics is headquartered in United States
When did Quince Therapeutics go public?
Quince Therapeutics initial public offering (IPO) was on 09 May 2019
What is Quince Therapeutics website?
https://www.quincetx.com
Is Quince Therapeutics in the S&P 500?
No, Quince Therapeutics is not included in the S&P 500 index
Is Quince Therapeutics in the NASDAQ 100?
No, Quince Therapeutics is not included in the NASDAQ 100 index
Is Quince Therapeutics in the Dow Jones?
No, Quince Therapeutics is not included in the Dow Jones index
When does Quince Therapeutics report earnings?
The next expected earnings date for Quince Therapeutics is 02 August 2024